AZO
56
4
ABT
57
3
SCHW
42
2
KO
44
3
ETR
71
2
MCK
56
3
ALL
43
6
ADT
43
2
ABBV
51
-4
EXR
37
15
AIZ
52
2
VTR
35
4
ADSK
61
4
ESS
42
3
KMB
28
-2
BAC
56
2
DTE
63
5
AIV
44
-3
MAT
58
9
LNC
28
-2
AZO
56
4
ABT
57
3
SCHW
42
2
KO
44
3
ETR
71
2
MCK
56
3
ALL
43
6
ADT
43
2
ABBV
51
-4
EXR
37
15
AIZ
52
2
VTR
35
4
ADSK
61
4
ESS
42
3
KMB
28
-2
BAC
56
2
DTE
63
5
AIV
44
-3
MAT
58
9
LNC
28
-2
Financhill
Back

Pacer Metaurus US Large Cap Div Multiplier 400 ETF Vs. Janux Therapeutics Industry Stock Comparison

Buy
79

QDPL
Pacer Metaurus US Large Cap Div Multiplier 400 ETF

Last Price:
$38.54
Seasonality Move:
2.46%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Buy
79
Pacer Metaurus US Large Cap Div Multiplier 400 ETF (QDPL) is a Buy

Is Pacer Metaurus US Large Cap Div Multiplier 400 ETF a Buy, Sell or Hold?

  • The current Pacer Metaurus US Large Cap Div Multiplier 400 ETF [QDPL] share price is $38.62. The Score for QDPL is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • QDPL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QDPL Stock Price Chart

What is Pacer Metaurus US Large Cap Div Multiplier 400 ETF's stock price today?

  • The Pacer Metaurus US Large Cap Div Multiplier 400 ETF share price today is $38.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QDPL is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

QDPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 41.64 Sell
Chaikin Money Flow: 85017 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.84 - 40.02) Sell
Bollinger Bands (100): (37.64 - 39.44) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

QDPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.79 Sell
20-day SMA: 39.29 Sell
50-day SMA: 39.23 Sell
200-day SMA: 37.34 Buy
8-day EMA: 38.82 Sell
20-day EMA: 39.11 Sell
50-day EMA: 39.07 Sell
200-day EMA: 37.38 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Pacer Metaurus US Large Cap Div Multiplier 400 ETF Earnings Growth & QDPL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Pacer Metaurus US Large Cap Div Multiplier 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):